About This Webinar
Please join us to hear from the Radiation Oncology department at UCLA Health on the overall impact COVID-19 may have on the practice of radiation oncology therapy moving forward. Learn how their team is leveraging MRIdian and adapting patient care to offer fewer fractions and ablative doses, including a case study on prostate SBRT. Drs. Steinberg and Kishan will also offer an overview of their MRIdian program and topline the promising clinical trials underway at UCLA that have the potential to reshape patient treatment in the future.

ABOUT UCLA Health

UCLA Health is among the most comprehensive and advanced health care systems in the world. Together, UCLA Health and the David Geffen School of Medicine at UCLA strive every day to be a model that redefines the standard of excellence in health care. It is our integrated mission to provide state-of-the-art patient care, to train top medical professionals and to support pioneering research and discovery. Our physicians are world leaders in the diagnosis and treatment of complex illnesses, and our hospitals are consistently ranked among the best in the nation by U.S. News & World Report. UCLA Health is at the cutting edge of biomedical research, and our doctors and scientists are pioneering work across an astounding range of disciplines, from organ transplantation and cardiac surgery to neurosurgery and cancer treatment and bringing the latest discoveries to virtually every field of medicine.
1590510745-4eae3793bb8000dc
Michael Steinberg, MD
Professor and Chair, Department of Radiation Oncology
Dr. Steinberg holds the academic rank of Professor and is the Chair of the Department of Radiation Oncology in the David Geffen School of Medicine at UCLA. He publishes and speaks on issues related to health policy including delivery and quality of care, patient safety, evidence-based validation of emerging technology, healthcare economics, disparity and value as well on a variety of clinical oncology topics. Dr. Steinberg’s clinical focuses are prostate cancer, breast cancer, and head and neck cancer. He currently serves as Director of Clinical Affairs for the Jonsson Comprehensive Cancer Center at UCLA. He served as the PI for a National Cancer Institute Cancer Disparity Research grant ($3.5 million) and as a health services research investigator and manuscript author at the RAND Corporation.

Dr. Steinberg has been influential on a national level in providing input regarding health policy and economic issues on behalf of patients and his specialty through his various leadership roles.  He is the founding Chair of the Health Policy Council of American Society for Radiation Oncology (ASTRO) and from 2010 to 2014, he was ASTRO’s President and Chairman of the Board. In 2017, Dr. Steinberg received the ASTRO Gold Medal for his contributions advancing patient care, research, and service to the specialty. Dr. Steinberg served for 8 years as the radiation oncology representative to the American Medical Association's CPT Editorial Panel and two terms on the CMS Medicare Evidence and Coverage Advisory Committee (MCAC).  He is currently a member of the California Technical Assessment Forum, a public technology and drug assessment organization that addresses the comparative effectiveness of medical treatments. 

From 2010 to 2014, Dr. Steinberg served as Chair of the Electronic Health Record Oversight Board (EOB), which strategically directed the implementation of the UCLA Health System’s electronic health record, Care Connect.  He now Chairs the IT Steering Committee for UCLA Health Sciences which includes oversight of Research Connect, the link between the enterprise clinical trials management system, and the electronic health record. In 2012, Dr. Steinberg was elected and then appointed by the Vice Chancellor as Chair of the Clinical Chairs in the David Geffen School of Medicine.  He was re-elected and appointed to this position again in 2017. He also currently serves on the Governing Group of UCLA Health.  

Dr. Steinberg graduated from Occidental College Phi Beta Kappa, was elected to AOA at the University of Southern California School of Medicine, and did his radiation oncology residency and fellowship at UCLA. 
1590510892-31b51d5a440941fb
Amar Kishan, MD
Radiation Oncologist and Assistant Professor
Dr. Amar U. Kishan, Assistant Professor, is the Vice Chair of Clinical and Translational Research and Chief of the Genitourinary Oncology Service for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center. Dr. Kishan graduated from the University of California, Berkeley with dual Bachelor of Arts degrees in Molecular and Cell Biology and Public Health. He earned his medical degree from Harvard Medical School, where he graduated magna cum laude from the joint Harvard-MIT Health Sciences and Technology Program. During medical school, he was awarded a Howard Hughes Medical Institute Fellowship to study tumor metabolism in the laboratory. He subsequently completed his internship training at Scripps Mercy Hospital in San Diego, where he was recognized as the H.H. Jones Intern of the Year. He then completed his residency training in radiation oncology at UCLA.

Dr. Kishan specializes in the utilization of radiation to treat genitourinary malignancies (particularly cancers of the prostate and bladder), as well as malignancies of the head and neck. He has an extensive research background and has published in leading journals such as JAMA, JAMA Oncology, European Urology, and Cancer Cell. He serves on several national committees and has received grant support from various national institutions, including the American Society of Radiation Oncology, the Radiological Society of North America, the Radiation Oncology Institute, and the Prostate Cancer Foundation.